InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by BURZIK CATHERINE M, Director. Director active across 4 companies, notably Orthofix Medical Inc.. In total, 9 disclosures have been recorded. Total volume traded: €88k. The latest transaction was filed on 6 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
08,844 shares0
Common Stock
SEC:0001209191-22-035049:0·
0820 shares0
Common Stock
SEC:0001062993-22-001643·
0820 shares0
Common Stock
SEC:0001062993-22-001643:0·
€44,2001,660 shares@ €26.62640.0073% mcap100.0% of flow
Common Stock
SEC:0001209191-21-065776·
Ideal exit: 16 Aug 2022 (T+270)
€44,2001,660 shares@ €26.62640.0073% mcap50.0% of flow
Common Stock
SEC:0001209191-21-065776:0·
Ideal exit: 16 Aug 2022 (T+270)
3,077 shares
Common Stock
SEC:0001127602-21-023391·
3,077 shares
Common Stock
SEC:0001127602-21-023391:0·
05,976 shares0
Common Stock
SEC:0001209191-21-042755·
05,976 shares0
Common Stock
SEC:0001209191-21-042755:0·
9 of 9 declarations
About BURZIK CATHERINE M
Catherine M. Burzik is a Director of Orthofix Medical Inc., Haemonetics Corp, and Becton Dickinson & Co. As a board member, she participates in overseeing the companies' activities and making strategic decisions. Her experience and skills in corporate governance are essential for guiding these companies in their growth and innovation objectives.
